Login / Signup

Editorial Comment on "Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease".

Syuya Kandori
Published in: International journal of urology : official journal of the Japanese Urological Association (2023)
Keyphrases
  • end stage renal disease
  • editorial comment
  • chronic kidney disease
  • renal cell carcinoma
  • peritoneal dialysis
  • open label
  • double blind
  • study protocol